Logo image of BLMN

BLOOMIN' BRANDS INC (BLMN) Stock Fundamental Analysis

NASDAQ:BLMN - US0942351083 - Common Stock

7.35 USD
+0.06 (+0.82%)
Last: 8/29/2025, 8:08:32 PM
7.35 USD
0 (0%)
After Hours: 8/29/2025, 8:08:32 PM
Fundamental Rating

3

Overall BLMN gets a fundamental rating of 3 out of 10. We evaluated BLMN against 131 industry peers in the Hotels, Restaurants & Leisure industry. BLMN has a medium profitability rating, but doesn't score so well on its financial health evaluation. BLMN has a bad growth rate and is valued cheaply.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year BLMN was profitable.
In the past year BLMN had a positive cash flow from operations.
In multiple years BLMN reported negative net income over the last 5 years.
Each year in the past 5 years BLMN had a positive operating cash flow.
BLMN Yearly Net Income VS EBIT VS OCF VS FCFBLMN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

1.2 Ratios

The Return On Assets of BLMN (-0.15%) is worse than 64.89% of its industry peers.
BLMN has a Return On Equity (-1.25%) which is in line with its industry peers.
With a Return On Invested Capital value of 4.48%, BLMN perfoms like the industry average, outperforming 44.27% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for BLMN is significantly below the industry average of 15.87%.
The last Return On Invested Capital (4.48%) for BLMN is well below the 3 year average (9.55%), which needs to be investigated, but indicates that BLMN had better years and this may not be a problem.
Industry RankSector Rank
ROA -0.15%
ROE -1.25%
ROIC 4.48%
ROA(3y)2.17%
ROA(5y)1.65%
ROE(3y)1.18%
ROE(5y)-770.59%
ROIC(3y)9.55%
ROIC(5y)N/A
BLMN Yearly ROA, ROE, ROICBLMN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

1.3 Margins

Looking at the Operating Margin, with a value of 3.89%, BLMN is doing worse than 67.94% of the companies in the same industry.
In the last couple of years the Operating Margin of BLMN has grown nicely.
BLMN's Gross Margin of 71.11% is amongst the best of the industry. BLMN outperforms 85.50% of its industry peers.
In the last couple of years the Gross Margin of BLMN has remained more or less at the same level.
Industry RankSector Rank
OM 3.89%
PM (TTM) N/A
GM 71.11%
OM growth 3Y-17.82%
OM growth 5Y1.66%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.36%
GM growth 5Y0.51%
BLMN Yearly Profit, Operating, Gross MarginsBLMN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), BLMN is creating some value.
The number of shares outstanding for BLMN has been reduced compared to 1 year ago.
Compared to 5 years ago, BLMN has less shares outstanding
BLMN has a worse debt/assets ratio than last year.
BLMN Yearly Shares OutstandingBLMN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BLMN Yearly Total Debt VS Total AssetsBLMN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

Based on the Altman-Z score of 0.86, we must say that BLMN is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of BLMN (0.86) is worse than 69.47% of its industry peers.
BLMN has a debt to FCF ratio of 15.15. This is a negative value and a sign of low solvency as BLMN would need 15.15 years to pay back of all of its debts.
BLMN has a Debt to FCF ratio of 15.15. This is comparable to the rest of the industry: BLMN outperforms 48.09% of its industry peers.
A Debt/Equity ratio of 2.34 is on the high side and indicates that BLMN has dependencies on debt financing.
BLMN has a Debt to Equity ratio (2.34) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 2.34
Debt/FCF 15.15
Altman-Z 0.86
ROIC/WACC0.5
WACC9.01%
BLMN Yearly LT Debt VS Equity VS FCFBLMN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

BLMN has a Current Ratio of 0.43. This is a bad value and indicates that BLMN is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.43, BLMN is doing worse than 80.92% of the companies in the same industry.
BLMN has a Quick Ratio of 0.43. This is a bad value and indicates that BLMN is not financially healthy enough and could expect problems in meeting its short term obligations.
BLMN's Quick ratio of 0.35 is on the low side compared to the rest of the industry. BLMN is outperformed by 79.39% of its industry peers.
Industry RankSector Rank
Current Ratio 0.43
Quick Ratio 0.35
BLMN Yearly Current Assets VS Current LiabilitesBLMN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

0

3. Growth

3.1 Past

The earnings per share for BLMN have decreased strongly by -37.08% in the last year.
The Earnings Per Share has been growing slightly by 3.30% on average over the past years.
BLMN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -19.61%.
BLMN shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.93% yearly.
EPS 1Y (TTM)-37.08%
EPS 3Y-12.64%
EPS 5Y3.3%
EPS Q2Q%-35.29%
Revenue 1Y (TTM)-19.61%
Revenue growth 3Y-1.41%
Revenue growth 5Y-0.93%
Sales Q2Q%-10.41%

3.2 Future

Based on estimates for the next years, BLMN will show a decrease in Earnings Per Share. The EPS will decrease by -9.66% on average per year.
The Revenue is expected to decrease by -2.95% on average over the next years.
EPS Next Y-39.54%
EPS Next 2Y-19.55%
EPS Next 3Y-9.66%
EPS Next 5YN/A
Revenue Next Year-11.39%
Revenue Next 2Y-5.15%
Revenue Next 3Y-2.95%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BLMN Yearly Revenue VS EstimatesBLMN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B
BLMN Yearly EPS VS EstimatesBLMN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 2

7

4. Valuation

4.1 Price/Earnings Ratio

BLMN is valuated cheaply with a Price/Earnings ratio of 4.87.
Based on the Price/Earnings ratio, BLMN is valued cheaper than 97.71% of the companies in the same industry.
BLMN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.08.
Based on the Price/Forward Earnings ratio of 6.31, the valuation of BLMN can be described as very cheap.
Based on the Price/Forward Earnings ratio, BLMN is valued cheaper than 96.18% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.72. BLMN is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 4.87
Fwd PE 6.31
BLMN Price Earnings VS Forward Price EarningsBLMN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

94.66% of the companies in the same industry are more expensive than BLMN, based on the Enterprise Value to EBITDA ratio.
BLMN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. BLMN is cheaper than 92.37% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.16
EV/EBITDA 4.87
BLMN Per share dataBLMN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

A cheap valuation may be justified as BLMN's earnings are expected to decrease with -9.66% in the coming years.
PEG (NY)N/A
PEG (5Y)1.47
EPS Next 2Y-19.55%
EPS Next 3Y-9.66%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 8.23%, BLMN is a good candidate for dividend investing.
BLMN's Dividend Yield is rather good when compared to the industry average which is at 4.19. BLMN pays more dividend than 95.42% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.34, BLMN pays a better dividend.
Industry RankSector Rank
Dividend Yield 8.23%

5.2 History

On average, the dividend of BLMN grows each year by 19.12%, which is quite nice.
BLMN has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of BLMN decreased in the last 3 years.
Dividend Growth(5Y)19.12%
Div Incr Years0
Div Non Decr Years2
BLMN Yearly Dividends per shareBLMN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

BLMN has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-1330.72%
EPS Next 2Y-19.55%
EPS Next 3Y-9.66%
BLMN Yearly Income VS Free CF VS DividendBLMN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

BLOOMIN' BRANDS INC

NASDAQ:BLMN (8/29/2025, 8:08:32 PM)

After market: 7.35 0 (0%)

7.35

+0.06 (+0.82%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)11-06 2025-11-06/bmo
Inst Owners103.54%
Inst Owner Change2.48%
Ins Owners1.65%
Ins Owner Change6.37%
Market Cap625.26M
Analysts54.44
Price Target7.7 (4.76%)
Short Float %8.76%
Short Ratio2.63
Dividend
Industry RankSector Rank
Dividend Yield 8.23%
Yearly Dividend0.96
Dividend Growth(5Y)19.12%
DP-1330.72%
Div Incr Years0
Div Non Decr Years2
Ex-Date08-19 2025-08-19 (0.15)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.74%
Min EPS beat(2)3.69%
Max EPS beat(2)13.79%
EPS beat(4)4
Avg EPS beat(4)5.28%
Min EPS beat(4)0.68%
Max EPS beat(4)13.79%
EPS beat(8)6
Avg EPS beat(8)1.3%
EPS beat(12)10
Avg EPS beat(12)3.14%
EPS beat(16)13
Avg EPS beat(16)4%
Revenue beat(2)0
Avg Revenue beat(2)-0.19%
Min Revenue beat(2)-0.32%
Max Revenue beat(2)-0.06%
Revenue beat(4)0
Avg Revenue beat(4)-0.83%
Min Revenue beat(4)-2.28%
Max Revenue beat(4)-0.06%
Revenue beat(8)0
Avg Revenue beat(8)-1.59%
Revenue beat(12)1
Avg Revenue beat(12)-1.69%
Revenue beat(16)2
Avg Revenue beat(16)-1.69%
PT rev (1m)-15.09%
PT rev (3m)-22.97%
EPS NQ rev (1m)-299.19%
EPS NQ rev (3m)-161.4%
EPS NY rev (1m)-11.8%
EPS NY rev (3m)-13.06%
Revenue NQ rev (1m)0.32%
Revenue NQ rev (3m)-5.88%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)0.1%
Valuation
Industry RankSector Rank
PE 4.87
Fwd PE 6.31
P/S 0.17
P/FCF 10.16
P/OCF 2.66
P/B 1.57
P/tB N/A
EV/EBITDA 4.87
EPS(TTM)1.51
EY20.54%
EPS(NY)1.16
Fwd EY15.85%
FCF(TTM)0.72
FCFY9.84%
OCF(TTM)2.76
OCFY37.59%
SpS43.36
BVpS4.67
TBVpS-3.12
PEG (NY)N/A
PEG (5Y)1.47
Profitability
Industry RankSector Rank
ROA -0.15%
ROE -1.25%
ROCE 5.66%
ROIC 4.48%
ROICexc 4.57%
ROICexgc 6.23%
OM 3.89%
PM (TTM) N/A
GM 71.11%
FCFM 1.67%
ROA(3y)2.17%
ROA(5y)1.65%
ROE(3y)1.18%
ROE(5y)-770.59%
ROIC(3y)9.55%
ROIC(5y)N/A
ROICexc(3y)9.93%
ROICexc(5y)N/A
ROICexgc(3y)14.52%
ROICexgc(5y)N/A
ROCE(3y)12.09%
ROCE(5y)N/A
ROICexcg growth 3Y-22.65%
ROICexcg growth 5Y1.95%
ROICexc growth 3Y-20.61%
ROICexc growth 5Y2.37%
OM growth 3Y-17.82%
OM growth 5Y1.66%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.36%
GM growth 5Y0.51%
F-Score6
Asset Turnover1.12
Health
Industry RankSector Rank
Debt/Equity 2.34
Debt/FCF 15.15
Debt/EBITDA 3.01
Cap/Depr 104.97%
Cap/Sales 4.7%
Interest Coverage 2.42
Cash Conversion 76.16%
Profit Quality N/A
Current Ratio 0.43
Quick Ratio 0.35
Altman-Z 0.86
F-Score6
WACC9.01%
ROIC/WACC0.5
Cap/Depr(3y)141.63%
Cap/Depr(5y)109.75%
Cap/Sales(3y)6.11%
Cap/Sales(5y)4.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-37.08%
EPS 3Y-12.64%
EPS 5Y3.3%
EPS Q2Q%-35.29%
EPS Next Y-39.54%
EPS Next 2Y-19.55%
EPS Next 3Y-9.66%
EPS Next 5YN/A
Revenue 1Y (TTM)-19.61%
Revenue growth 3Y-1.41%
Revenue growth 5Y-0.93%
Sales Q2Q%-10.41%
Revenue Next Year-11.39%
Revenue Next 2Y-5.15%
Revenue Next 3Y-2.95%
Revenue Next 5YN/A
EBIT growth 1Y-52.2%
EBIT growth 3Y-18.98%
EBIT growth 5Y0.71%
EBIT Next Year32.57%
EBIT Next 3Y12.2%
EBIT Next 5YN/A
FCF growth 1Y-64.71%
FCF growth 3Y-70.21%
FCF growth 5Y-45.63%
OCF growth 1Y-48.83%
OCF growth 3Y-17.24%
OCF growth 5Y-6.4%